Key result
Aripiprazole and other atypical antipsychotics carry a risk of cardiovascular side effects such as QT prolongation and severe arrhythmias, highlighting the need for careful cardiac monitoring.
Atypical antipsychotics like aripiprazole pose significant risks of QT prolongation and sudden cardiac death, highlighting the need for cardiovascular risk assessment and ECG monitoring in psychiatric patients.
Supports ECG monitoring with aripiprazole; leaves open optimal protocols and comparative risk quantification.
The known cause of cardiac conduction disturbances predicts the cardiovascular side effects inducing severe arrhythmia by the use of atypical antipsychotic i.e. Aripiprazole The efficacies in co-morbidities absolutely risk the warning detection of sudden death cause with major mental disorders interacting the mechanism in the predisposing malignancy factors. Therefore, we believe to improve dose-dependent inhibition coding the life-threatening ventricular tachycardia based on cardiac toxicity issue regulate the evaluation of testing drug criteria in clinical practice.
No takes yet. Share an insight, caveat, or question.
Iftikhar et al. (2018) conducted a review in Cardiovascular disease and psychiatric disorders. Aripiprazole was evaluated. Aripiprazole and other atypical antipsychotics carry a risk of cardiovascular side effects such as QT prolongation and severe arrhythmias, highlighting the need for careful cardiac monitoring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: